Federal contract award
75A50122C00052
TO DEVELOP RITCA AS AN ONLINE AND MOBILE PHONE-BASED APPLICATION. RITCA WILL SERVE AS A DISASTER RESPONSE TOOL FOR A REGIONAL AREA WITHIN THE BROAD RANGE OF THE MEDICAL RESPONDER COMMUNITY. THIS APPLICATION WILL ALLOW FOR SYNCHRONOUS AND ASYNCHR
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| PSC | Q701 — Specialized Medical Support |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $49.2M |
| Current contract value | $49.2M |
| Potential contract value / ceiling | $49.2M |
| Start date | Sep 21, 2022 |
| Current end date | Sep 30, 2028 |
| Potential end date | Sep 30, 2028 |
| Latest award activity | Sep 3, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 25 of 25 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Sep 3, 2026 | P00024 | $0 | EXTEND THE POP FOR CLIN 0012 FROM SEPTEMBER 30, 2026, THROUGH OCTOBER 31, 2026, TO PROVIDE ADDITIONAL TIME FOR COMPLETION OF THE EXISTING NMSCC SUPPORT REQUIREMENTS. |
| Jul 28, 2026 | P00023 | $0 | DESIGNATE JANELLE HURWITZ AS THE PRIMARY COR AND REVISE SECTION G.3, KEY PERSONNEL. |
| Jun 5, 2026 | P00022 | $5.2M | EO 14398, UPDATED HHSAR CLAUSES, EXERCISE CLIN 0008 AND CLIN 0009, UPDATED SOW AND EXTEND THE POP FOR CLIN 0015 TO 9/30/28. |
| May 18, 2026 | P00021 | $546.6K | THE PURPOSE OF THIS MODIFICATION IS TO INCREASE THE FUNDING FROM $652,913.00 BY $546,589.00 TO $1,199,502.00. EXTEND THE PERIOD OF PERFORMANCE END DATE TO SEPTEMBER 30, 2028 FOR CLIN 0010 AND INCORPORATE THE UPDATED STATEMENT OF WORK. |
| Apr 14, 2026 | P00020 | $1.5M | EXTEND THE PERIOD OF PERFORMANCE (POP) FOR CLIN 0012 FROM APRIL 20, 2026 TO SEPTEMBER 30, 2026 AND REVISE THE SOW. |
| Mar 11, 2026 | P00019 | $0 | EOI::EO: RADICAL TRANSPARENCY ABOUT WASTEFUL SPENDING::EOI UNILATERAL MODIFICATION TO CORRECT FPDS-NG REPORTING IAW ACQUISITION ALERT 2025-04 AMENDMENT 2. |
| Feb 23, 2026 | P00018 | $0 | THE PURPOSE OF THIS NO COST MODIFICATION IS TO EXTEND THE PERIOD OF PERFORMANCE FOR CLIN 0012 UNTIL 20 APRIL 2026. |
| Feb 2, 2026 | P00017 | $0 | THE PURPOSE OF THIS NO COST MODIFICATION IS TO UPDATE PART 1 - THE SCHEDULE, SECTION G- CONTRACT ADMINISTRATION, G.3. KEY PERSONNEL, HHSAR 352.237-75 (DECEMBER 2015) |
| Dec 9, 2025 | P00016 | $750.0K | EXTEND PERIOD OF PERFORMANCE (POP) FOR CLIN 0012 FROM DECEMBER 20, 2025, TO MARCH 20, 2026. |
| Nov 26, 2025 | P00015 | $0 | THE PURPOSE OF THIS BILATERAL MODIFICATION IS A NO COST EXTENSION OF CLIN 0012 UNTIL 22 DECEMBER 2025. |
| Jun 18, 2025 | P00014 | $-2.8M | THE PURPOSE OF THIS MODIFICATION IS TO: 1. DECREASE CLIN 0011 FROM $4,612,835.00 BY $14,184.00 TO $4,598,651.00 2. DECREASE CLIN 0012 FROM $19,236,000.00 BY $1,010,113.00 TO $18,225,887.00. 3. DECREASE CLIN 0017 FROM $4,194,000.00 BY $1,797,107.00 |
| Jan 29, 2025 | P00013 | $0 | NO COST EXTENSION FOR CLINS 0005, CLIN 0011, AND CLIN 0017. |
| Jan 15, 2025 | P00012 | $2.8M | EXERCISE CLINS 006, 007, AND 010 AND REVISE THE SOW. |
| Oct 17, 2024 | P00011 | $0 | NO COST EXTENSION FOR CLINS 11 PERIOD OF PERFORMANCE END DATE TO 02/28/2025. |
| Oct 9, 2024 | P00010 | $0 | NO COST MODIFICATION TO EXTEND CLINS 17 TASK 17.1 DELIVERABLE TO 12/31/2024. |
| Sep 4, 2024 | P00009 | $0 | THE PURPOSE OF THIS NO COST MODIFICATION IS TO EXTEND THE PERIODS OF PERFORMANCE FOR CLIN 0005, CLIN 0013 AND CLIN 0016 AND ADD CLARIFYING LANGUAGE TO SECTION B OF THE CONTRACT. A. CLIN 0005: THE PERIOD OF PERFORMANCE END DATE IS HEREBY EXTENDED TO |
| Jan 19, 2024 | P00008 | $2.4M | SUPPLEMENTAL FUNDING FOR CLIN 0011 AND 0013. |
| Jan 9, 2024 | P00007 | $10.6M | SUPPLEMENTAL FUNDING FOR CLIN 0012, ADD OPTIONAL CLIN 0017, REVISE KEY PERSONNEL, AND UPDATE THE STATEMENT OF WORK. |
| Nov 20, 2023 | P00006 | $0 | NO COST EXTENSION FOR CLINS 0011 AND 0013. PERIOD OF PERFORMANCE IS REVISED TO 12/2/2022-02/28/2023. |
| Sep 26, 2023 | P00005 | $1.8M | SUPPLEMENTAL FUNDING FOR CLIN 00014 TO PROVIDE GENERAL DATA MANAGEMENT AND ANALYTIC EXPERTISE TO SUPPORT ASPR TESTING AND DIAGNOSTIC ANALYTIC PRIORITIES. |
| Sep 22, 2023 | P00004 | $8.5M | REVISING STATEMENT OF WORK AND SUPPLEMENTAL FUNDING FOR CLIN 0012 AND ADDING CLIN 0016 FOR CYBERSECURITY. |
| May 2, 2023 | P00003 | $574.3K | FUNDING FOR CLIN 0015 FOR SAB AND OTHER STAKEHOLDERS TRAVEL. |
| Mar 14, 2023 | P00002 | $1.1M | ADD SUPPLEMENTAL FUNDING AND REVISE SECTIONS B.4, F.4, AND THE STATEMENT OF WORK. |
| Dec 28, 2022 | P00001 | $11.5M | TO EXERCISE OPTIONAL CLINS AND REVISE STATEMENT OF WORK. |
| Sep 21, 2022 | 0 | $4.9M | TO DEVELOP RITCA AS AN ONLINE AND MOBILE PHONE-BASED APPLICATION. RITCA WILL SERVE AS A DISASTER RESPONSE TOOL FOR A REGIONAL AREA WITHIN THE BROAD RANGE OF THE MEDICAL RESPONDER COMMUNITY. THIS APPLICATION WILL ALLOW FOR SYNCHRONOUS AND ASYNCHR |
Estimated positioning window
Sep 30, 2027 – Mar 30, 2028
Recompete signal: . Rule-based research score; positioning dates are estimates.
60/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 60/100. Available recorded signals: 55 points.
- Contract end 2028-09-30 (699 days from calculation)
- +25 points
- 4 historical awards in this buyer and category group
- +15 points
- 25 recorded award transactions
- +10 points
- Latest award action: 2026-09-03
- +5 points
- Parent award identifier recorded
- +0 points
- Solicitation identifier recorded
- +0 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-11-01 10:17:53.997580+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Nov 1, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.